-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSI-GSD-200 in Rift Valley Fever
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSI-GSD-200 in Rift Valley Fever report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TSI-GSD-200 in Rift Valley Fever Drug Details: TSI-GSD 200 vaccine is...
-
Product Insights
NewMedMira Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MedMira Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. The company serves hospitals, point-of-care facilities, laboratories, governments, public health...
-
Company Insights
Enterprise Tech Ecosystem Series: Roche Holding AG
Roche joined forces with GE Healthcare to combine both companies’ capabilities and leverage big data, machine learning, genomics, and imaging technologies to develop decision support tools for clinicians, and help them take data-driven and personalized decisions at each stage of patients’ diseases. In 2013, Roche and California Institute for Quantitative Biosciences (QB3) formed a strategic alliance to create a venture arm, Mission Bay Capital, in order to identify, support, and invest in early stage start-ups focusing on life science, and...